Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheri L Spunt

Showing results (41-50 of 165) with videos related to

Pageof 17
Sort By:
Pediatric Blood & Cancer|August 15, 2023
Tyrosine kinase inhibitor therapy in pediatric sarcoma: Prognostic implications of pulmonary metastatic cavitationWipawee Morakote, Lisa C Adams, Shakthi K Ramasamy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Phase II, randomized, open-label study of pegfilgrastim-supported VDC/IE chemotherapy in pediatric sarcoma patientsSheri L Spunt, Helen Irving, Jami Frost, et al.
The Lancet. Oncology|October 11, 2018
Advancing shared decision making for symptom monitoring in people living beyond cancerLauren C Heathcote, Daniel S Goldberg, Christopher Eccleston, et al.
Journal of Pediatric Surgery|October 27, 2009
Body wall and visceral nonrhabdomyosarcoma soft tissue sarcomas in children and adolescentsFariba Navid, Catherine A Billups, Matthew J Krasin, et al.
Pediatric Blood & Cancer|September 27, 2021
Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic reviewLucy Y Liu, Joyce M C Teng, Sheri L Spunt, et al.
Journal of Pediatric Hematology/Oncology|May 1, 2024
Favorable Outcome of High-grade Endometrial Stromal Sarcoma in an AdolescentBenjamin Hu, Brooke E Howitt, Stephanie Cizek, et al.
Cancer|July 16, 2011
Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeAbha A Gupta, James R Anderson, Alberto S Pappo, et al.
Cancer|May 25, 2006
Ewing sarcoma-family tumors that arise after treatment of primary childhood cancerSheri L Spunt, Carlos Rodriguez-Galindo, Christine E Fuller, et al.
AJR. American Journal of Roentgenology|November 22, 2014
Imaging features of alveolar soft-part sarcoma: a report from Children's Oncology Group Study ARST0332M Beth McCarville, Sofia Muzzafar, Simon C Kao, et al.
Molecular Imaging and Biology|September 7, 2018
Association of Tumor [<sup>18</sup>F]FDG Activity and Diffusion Restriction with Clinical Outcomes of RhabdomyosarcomasArian Pourmehdi Lahiji, Tatianie Jackson, Hossein Nejadnik, et al.
Pageof 17

Showing results (41-50 of 165) with videos related to

Sort By:
Pageof 17
Pediatric Blood & Cancer|August 15, 2023
Tyrosine kinase inhibitor therapy in pediatric sarcoma: Prognostic implications of pulmonary metastatic cavitationWipawee Morakote, Lisa C Adams, Shakthi K Ramasamy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Phase II, randomized, open-label study of pegfilgrastim-supported VDC/IE chemotherapy in pediatric sarcoma patientsSheri L Spunt, Helen Irving, Jami Frost, et al.
The Lancet. Oncology|October 11, 2018
Advancing shared decision making for symptom monitoring in people living beyond cancerLauren C Heathcote, Daniel S Goldberg, Christopher Eccleston, et al.
Journal of Pediatric Surgery|October 27, 2009
Body wall and visceral nonrhabdomyosarcoma soft tissue sarcomas in children and adolescentsFariba Navid, Catherine A Billups, Matthew J Krasin, et al.
Pediatric Blood & Cancer|September 27, 2021
Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic reviewLucy Y Liu, Joyce M C Teng, Sheri L Spunt, et al.
Journal of Pediatric Hematology/Oncology|May 1, 2024
Favorable Outcome of High-grade Endometrial Stromal Sarcoma in an AdolescentBenjamin Hu, Brooke E Howitt, Stephanie Cizek, et al.
Cancer|July 16, 2011
Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeAbha A Gupta, James R Anderson, Alberto S Pappo, et al.
Cancer|May 25, 2006
Ewing sarcoma-family tumors that arise after treatment of primary childhood cancerSheri L Spunt, Carlos Rodriguez-Galindo, Christine E Fuller, et al.
AJR. American Journal of Roentgenology|November 22, 2014
Imaging features of alveolar soft-part sarcoma: a report from Children's Oncology Group Study ARST0332M Beth McCarville, Sofia Muzzafar, Simon C Kao, et al.
Molecular Imaging and Biology|September 7, 2018
Association of Tumor [<sup>18</sup>F]FDG Activity and Diffusion Restriction with Clinical Outcomes of RhabdomyosarcomasArian Pourmehdi Lahiji, Tatianie Jackson, Hossein Nejadnik, et al.
Pageof 17